MX9707295A - Metodo para mejorar la respuesta de los anticuerpos a los antigenos especificos con interleucina-10. - Google Patents
Metodo para mejorar la respuesta de los anticuerpos a los antigenos especificos con interleucina-10.Info
- Publication number
- MX9707295A MX9707295A MX9707295A MX9707295A MX9707295A MX 9707295 A MX9707295 A MX 9707295A MX 9707295 A MX9707295 A MX 9707295A MX 9707295 A MX9707295 A MX 9707295A MX 9707295 A MX9707295 A MX 9707295A
- Authority
- MX
- Mexico
- Prior art keywords
- enhancing
- interleukin
- antibody response
- specific antigens
- vaccine
- Prior art date
Links
- 102000003814 Interleukin-10 Human genes 0.000 title abstract 3
- 108090000174 Interleukin-10 Proteins 0.000 title abstract 3
- 239000000427 antigen Substances 0.000 title abstract 2
- 102000036639 antigens Human genes 0.000 title abstract 2
- 108091007433 antigens Proteins 0.000 title abstract 2
- 230000002708 enhancing effect Effects 0.000 title abstract 2
- 230000005875 antibody response Effects 0.000 title 1
- 229940076144 interleukin-10 Drugs 0.000 title 1
- 241000124008 Mammalia Species 0.000 abstract 2
- 229960005486 vaccine Drugs 0.000 abstract 2
- 239000003937 drug carrier Substances 0.000 abstract 1
- 230000028993 immune response Effects 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/19—Cytokines; Lymphokines; Interferons
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/39—Medicinal preparations containing antigens or antibodies characterised by the immunostimulating additives, e.g. chemical adjuvants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/02—Bacterial antigens
- A61K39/09—Lactobacillales, e.g. aerococcus, enterococcus, lactobacillus, lactococcus, streptococcus
- A61K39/092—Streptococcus
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A61K2039/55522—Cytokines; Lymphokines; Interferons
- A61K2039/55527—Interleukins
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Mycology (AREA)
- Microbiology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Organic Chemistry (AREA)
- Zoology (AREA)
- Gastroenterology & Hepatology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
Abstract
La presente invencion se refiere a un método para mejorar la respuesta inmune de un mamífero a una vacuna, el método comprende la administracion, a este mamífero, de un cantidad efectiva de IL-10 junto con la vacuna. Una composicion farmacéutica que contiene una cantidad efectiva de IL-10, un antígeno natural, sintético o recombinante y un portador farmacéuticamente aceptable.
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US08/410,199 US5866134A (en) | 1995-03-24 | 1995-03-24 | Method for enhancing the antibody response to specific antigens with Interleukin-10 |
| US08410199 | 1995-03-24 | ||
| PCT/US1996/003311 WO1996030039A1 (en) | 1995-03-24 | 1996-03-21 | Method for enhancing the antibody response to specific antigens with interleukin-10 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| MX9707295A true MX9707295A (es) | 1997-11-29 |
| MXPA97007295A MXPA97007295A (es) | 1998-07-03 |
Family
ID=
Also Published As
| Publication number | Publication date |
|---|---|
| WO1996030039A1 (en) | 1996-10-03 |
| AU711087B2 (en) | 1999-10-07 |
| AU5189096A (en) | 1996-10-16 |
| JPH11502533A (ja) | 1999-03-02 |
| US5866134A (en) | 1999-02-02 |
| KR19980703251A (ko) | 1998-10-15 |
| NZ304640A (en) | 1999-07-29 |
| HUP9801223A2 (hu) | 1998-08-28 |
| HUP9801223A3 (en) | 2000-12-28 |
| CA2215968A1 (en) | 1996-10-03 |
| EP0814829A1 (en) | 1998-01-07 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX9304089A (es) | Uso de gm-csf como una vacuna adyuvante. | |
| EP0618813A4 (en) | Antigen of hybrid m protein and carrier for group a streptococcal vaccine. | |
| IL102687A (en) | Conjugates of poorly immunogenic antigens and synthetic pepide carriers and vaccines comprising them | |
| AU7980794A (en) | Methods and compositions for microencapsulation of antigens for use as vaccines | |
| AU709406C (en) | Combined vaccines comprising hepatitis B surface antigen and other antigens | |
| FI955101A7 (fi) | Immunogeenisia LHRH-peptidirakenteita ja synteettisiä immunosysteemin yleisstimulaattoreita rokotteita varten | |
| EA199700272A1 (ru) | Вакцины, содержащие сапонин и стерин | |
| CA2267072A1 (en) | Reconstituted human anti-hm1.24 antibody | |
| IE900502L (en) | Conjugates | |
| AU6832398A (en) | Multiple antigen glycopeptide carbohydrate, vaccine comprising the same and use thereof | |
| ES8608883A1 (es) | Procedimiento de preparacion de un conjugado de muramilpeptido y de un hapteno o fragmento haptenico de bajo peso molecular. | |
| MY135673A (en) | Monoclonal antibodies for inducing tolerance | |
| HUP9801223A2 (hu) | Eljárás specifikus antigénekre adott antitest válasz fokozására interleukin-10-zel | |
| WO1994010317A3 (en) | Conjugate vaccine against group b streptococcus | |
| WO2000069915A3 (en) | COMBINED APPROACH TO TREATMENT OF CANCER WITH hCG VACCINES | |
| AU1749292A (en) | Recombinant hybrid porin epitopes | |
| HU9301797D0 (en) | Utilization of il-4 for producing pharmaceutical preparatives improving immunoreaction | |
| EP0153871A3 (en) | Antibody enhancement of immunogenicity of antigen | |
| AU4803785A (en) | Cross-reactive and protective epitopes of circumsporozoite proteins | |
| CA2128247A1 (en) | Vaccines based on streptokinase | |
| CA2133108A1 (en) | Pasteurella haemolytica type a-1 bacterin-toxoid vaccine | |
| NZ532271A (en) | Peptide mimics of conserved gonococcal epitopes and methods and compositions using them | |
| NZ223624A (en) | Peptide immunogen from streptococcus mutans, vaccines and antibodies | |
| DE69322960D1 (de) | Empfängnisverhütender impfstoff | |
| AU3752489A (en) | Immunogenic human interleukin-3 peptide and monoclonal antibodies thereto |